Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP951497priorityCriticalpatent/ECSP951497A/en
Publication of ECSP951497ApublicationCriticalpatent/ECSP951497A/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Abstract
El invento se refiere a una nueva proteína mayor de leishamanias así como la secuencia de acido nucleico codante para esta proteína, y la utilización de la misma particularmente para la preparación de una vacuna contra la leishamaniosis en los mamíferos y mas particularmente en el hombre y el perro.The invention relates to a new major protein of leishamania as well as the sequence of nucleic acid codante for this protein, and the use of the same particularly for the preparation of a vaccine against leishamaniosis in mammals and more particularly in man and the dog.
ECSP9514971995-08-031995-08-03
MAJOR PROTEIN OF LEISHMANIAS NUCLEIC ACID CODANT FOR THIS PROTEIN AND ITS APPLICATIONS
ECSP951497A
(en)
Use of a composition for the supply of a bactericidal hormone, peptide or protein or peptide or insecticidal protein comprising a disabled algal cell expressing said hormone, peptide or protein to induce enhanced growth, antibacterial or insecticidal activity (div.sol.no. 1360-02).
METALOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PHARMACEUTICAL USE AND METHODS AND EFFECTIVE INTERMEDIATE PRODUCT FOR THEIR PREPARATION.